Home
About Us
Background
Investment Strategy
Team
Portfolio
News
Contact
中文
Investor Login
Home
About Us
Background
Investment Strategy
Team
Portfolio
News
Contact
中文
Investor Login
We are Company Builders
Identifying, incubating and growing future industry leaders in life sciences.
We are Industry Veterans
Capturing evolving healthcare trends and emerging cutting-edge innovations
We are Preferred Partners
Connecting companies with extensive network and resources globally and in China
Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
...
March 18, 2026
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
...
March 11, 2026
Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel
...
February 23, 2026
All news